Tauro-β-muricholic Acid-d4 (sodium salt)

Tauro-β-muricholic Acid-d4 (sodium salt) （订货以CAS编码或英文名称为准）

Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Bile Acids|Bile Acid Conjugates||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Biliary System|Bile Acid Receptors||Research Area|Endocrinology & Metabolism|Hormones & Receptors|FXRs & LXRs||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55846

分子式：C21H23N5O3F6

CAS号：486460-23-5

分子量：507.43

储存条件：-20

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55846-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55846-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55846-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55846-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55846-1mg	Medlife	EA		¥8717.00	登录后可见

中文名称：	Sitagliptin N-Boc Impurity
中文别名：	叔丁氧羰基-西他列汀;西他列汀N-BOC 杂质;西他列汀N-叔丁氧羰杂质
英文名称：	Tauro-β-muricholic Acid-d4 (sodium salt)
英文别名：	Sitagliptin N-Boc Impurity;Boc-Sitagliptin;N-Boc-Sitagliptin;tert-butyl N-[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]carbamate
CAS号：	486460-23-5
分子式：	C21H23N5O3F6
分子量：	507.43
详细描述	Application\|Mass Spectrometry\|\|Product Type\|Biochemicals\|Analytical Standards\|\|Product Type\|Biochemicals\|Bile Acids\|Bile Acid Conjugates\|\|Product Type\|Biochemicals\|Isotopically Labeled Standards\|Deuterium\|\|Product Type\|Biochemicals\|Lipids\|Sterol Lipids\|\|Product Type\|Biochemicals\|Receptor Pharmacology\|Antagonists\|\|Research Area\|Endocrinology & Metabolism\|Biliary System\|Bile Acid Receptors\|\|Research Area\|Endocrinology & Metabolism\|Hormones & Receptors\|FXRs & LXRs\|\|Research Area\|Endocrinology & Metabolism\|Metabolic Diseases\|Diabetes\|\|Research Area\|Endocrinology & Metabolism\|Metabolic Diseases\|NAFLD & NASH\|\|Research Area\|Endocrinology & Metabolism\|Metabolic Diseases\|Obesity